Stock Information

Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics, Inc. logo
Ticker Symbol: HALO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $11,380.44 mil
Piotroski score: 7
PE Ratio: 25.65
EPS (TTM): 3.35
Revenue (TTM): $13.73 M
Dividend Yield: N/A
ROE: 180.63%